These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Kristensen M, Deleuran B, Eedy DJ, Feldmann M, Breathnach SM, Brennan FM. Br J Dermatol; 1992 Oct; 127(4):305-11. PubMed ID: 1419749 [Abstract] [Full Text] [Related]
25. Expression and Function of VEGFRs in Normal Epidermis and Psoriatic Lesional Keratinocytes. Wang Y, Yan Y, Yu H, Jiang G, Zhao S, Yi M. Cell Mol Biol (Noisy-le-grand); 2023 Aug 31; 69(8):50-56. PubMed ID: 37715429 [Abstract] [Full Text] [Related]
31. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. J Exp Med; 1996 Nov 01; 184(5):2007-12. PubMed ID: 8920887 [Abstract] [Full Text] [Related]
32. Interleukin-6 in psoriasis: expression and mitogenicity studies. Elder JT, Sartor CI, Boman DK, Benrazavi S, Fisher GJ, Pittelkow MR. Arch Dermatol Res; 1992 Nov 01; 284(6):324-32. PubMed ID: 1294020 [Abstract] [Full Text] [Related]
33. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? Rückert R, Asadullah K, Seifert M, Budagian VM, Arnold R, Trombotto C, Paus R, Bulfone-Paus S. J Immunol; 2000 Aug 15; 165(4):2240-50. PubMed ID: 10925312 [Abstract] [Full Text] [Related]
34. Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. Kulke R, Tödt-Pingel I, Rademacher D, Röwert J, Schröder JM, Christophers E. J Invest Dermatol; 1996 Mar 15; 106(3):526-30. PubMed ID: 8648188 [Abstract] [Full Text] [Related]
35. Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. Cancino-Díaz JC, Reyes-Maldonado E, Bañuelos-Pánuco CA, Jiménez-Zamudio L, García-Latorre E, León-Dorantes G, Blancas-González F, Paredes-Cabrera G, Cancino-Díaz ME. J Invest Dermatol; 2002 Nov 15; 119(5):1114-20. PubMed ID: 12445201 [Abstract] [Full Text] [Related]
37. Persistent expression of interleukin-17 and downstream effector cytokines in recalcitrant psoriatic lesions after ustekinumab treatment. Kim BR, Kim M, Yang S, Choi CW, Lee KS, Youn SW. J Dermatol; 2021 Jun 15; 48(6):876-882. PubMed ID: 33860544 [Abstract] [Full Text] [Related]
38. A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions. Cheng J, Tu Y, Li J, Huang C, Liu Z, Liu D. J Tongji Med Univ; 2001 Jun 15; 21(1):86-8. PubMed ID: 11523260 [Abstract] [Full Text] [Related]
39. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. Kojima T, Cromie MA, Fisher GJ, Voorhees JJ, Elder JT. J Invest Dermatol; 1993 Dec 15; 101(6):767-72. PubMed ID: 8245503 [Abstract] [Full Text] [Related]